Account

Developing the right pricing strategy for your product

We use a variety of pricing techniques and approaches to recommend the optimum value-based pricing for your product.

How can we support you:
Payer Insights
Pricing Strategy
BD Commercial Assessments
Tactical Pricing

We can help you

  • Obtain payer and stakeholder insights into the perceived value of your product
  • Identify the optimal price for your product
  • Determine the global pricing strategy
  • Understand payer evidence requirements to support your value-based pricing and reimbursement strategy
  • Conduct commercial assessments for business development assets
  • Implement pricing tactics to optimize post-launch pricing at a list and net price level
Get in touch

Discover the latest insights

MFN Drug Pricing Proposal: What It Could Mean for …
Negotiations between the Trump administration and pharmaceutical companies on lowering U.S…
Read more
Your 5-step ATMP pricing playbook for launch succe…
Advanced Therapy Medicinal Products (ATMPs) are offering transformative, and often life-saving, trea…
Read more
ATMP Pricing in Practice: Success & Cautionary…
Advanced Therapy Medicinal Products (ATMPs) are leading in healthcare innovation, providing potentia…
Read more
Why Gene Therapies Keep Hitting Price & Access…
The pricing benchmark has shifted faster than systems have adapted. In the UK, prices for one-time t…
Read more
Innovative Payment Models: Outcomes‑Based, Annui…
In 2010, the world’s most expensive therapy was Soliris (eculizumab), costing around USD 409,500 p…
Read more
ATMP pricing landscape: why traditional models bre…
A €3 million invoice for a single infusion can dazzle as easily as it alarms. Gene therapies such …
Read more
Proving LongTerm Value: Evidence Strategies Payers…
Proving the long-term value of pharmaceutical assets remains one of the biggest challenges for manuf…
Read more
World EPA 2025: Evaluating the capabilities of AI …
AUTHORS: Ella Odams, Richard Sloggett, Graham Foxon OBJECTIVES  To evaluate if ChatGPT is a rel…
Read more
Spain
A closer look at Spain’s new pharmaceutical acce…
Spain is set to implement a comprehensive reform to its law of guarantees and rational use of medici…
Read more
EU HTA process
ISPOR Europe 2024
We’re delighted to announce our participation at ISPOR Europe 2024 in Barcelona this November. We’ll…
Read more

I really enjoyed working with Remap Consulting and received powerful advice. A small company like ours needs to receive a flexible approach in order start with market access activities, and I am very happy to see you are as flexible as possible with us.

Director of Market Access
Small pharma payer insights for clinical trials

Remap Consulting’s pricing knowledge and support has been critical to the success of our new pricing team. Their combined experience has provided them with ‘real-world‘ knowledge that can support their recommendations. I highly recommend Remap Consulting and am delighted to continue my work with their pricing group.

Senior Director, Head of Global Pricing
Outsourcing pricing activities for large biotech

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch